Herpes Simplex: all 302 studies
Page 1 of 4. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)Enrolling by invitationNCT07633197Phase 1
- Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic DiseasesRecruitingNCT07341386Phase 4
- Quantification & Classification of Inflammatory Cells in Uveitis Using OCTRecruitingNCT07065747
- Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover OptionNot yet recruitingNCT07032649Phase 2
- Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High VoltageRecruitingNCT06978192Phase 2
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and OlderNot yet recruitingNCT06961721Phase 4
- High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated NeuralgiaRecruitingNCT06959147Phase 4
- The Efficacy of High-frequency Short-time Spinal Cord Stimulation in the Treatment of Herpes Zoster-associated NeuralgiaRecruitingNCT06942806
- Herpes Simplex Virus Type 1 Infection/Reactivation of Patients With Severe Pneumonia（the HSV-SP Study）Not yet recruitingNCT06936683
- Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated PainNot yet recruitingNCT06914206Not applicable
- Neuropathic Pain and Traditional Medicine Syndromes in Herpes Zoster: a Cross-Sectional StudyNot yet recruitingNCT06870877
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster VaccineNot yet recruitingNCT06801509Phase 1/2
- Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster PainNot yet recruitingNCT06798662Not applicable
- Impact on Quality of Life and Burden of Disease in Adults With Herpes ZosterNot yet recruitingNCT06667245
- Herpes Simplex Meningo Encephalitis RecurrenceRecruitingNCT06627010
- Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes ZosterNot yet recruitingNCT06476080Not applicable
- A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal KeratitisRecruitingNCT06474442Phase 2
- Hand Sanitizer Use for Herpes Simplex Virus-1RecruitingNCT06135844Early Phase 1
- Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BALRecruitingNCT06134492Phase 3
- A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster VaccineRecruitingNCT06088745Phase 3
- Herpes Zoster Hospitalizations in ItalyRecruitingNCT05952271
- Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2AvailableNCT05844436
- Epidural Platelet Rich Plasma Injection for Herpes ZosterRecruitingNCT05538364
- Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal MorbidityRecruitingNCT05429346
- Bronchoscopic Score for Prediction of Herpes Simplex-virus Type 1 (HSV-1) ReactivationRecruitingNCT05331417
- Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric PatientsRecruitingNCT05198570
- Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.RecruitingNCT04065971Phase 4
- Natural History Study of GATA2 Deficiency and Related DisordersRecruitingNCT01905826
- The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known ImmunocompromiseRecruitingNCT01011712
- Genetic Studies of Chronic Active Epstein-Barr DiseaseRecruitingNCT00032513
- A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 YearsCompletedNCT05989672Phase 1Results posted
- Potential Influence of Esomeprazole on the Pharmacokinetics of PritelivirCompletedNCT05513625Phase 1Results posted
- Neonatal Phase 1 Valacyclovir StudyCompletedNCT05468619Phase 1Results posted
- A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in IndiaCompletedNCT05219253Phase 3Results posted
- Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With VedolizumabCompletedNCT03798691Phase 4Results posted
- Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)CompletedNCT03661541Phase 1Results posted
- A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes LabialisTerminatedNCT03521479Phase 2Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and OlderCompletedNCT03439657Phase 3Results posted
- Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes InfectionTerminatedNCT03146403Phase 2Results posted
- Zoster Eye Disease StudyCompletedNCT03134196Phase 4Results posted
- Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of AgeCompletedNCT02979639Phase 3Results posted
- Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes LabialisCompletedNCT02965781Phase 1/2Results posted
- Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial HerpesCompletedNCT02871492Phase 2Results posted
- Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and OlderCompletedNCT02735915Phase 3Results posted
- Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.CompletedNCT02690207Phase 3Results posted
- Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR TestCompletedNCT02685956Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years EarlierCompletedNCT02581410Phase 3Results posted
- Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in FranceCompletedNCT02487472Results posted
- Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster KeratitisTerminatedNCT02382588Phase 2Results posted
- Open-label Study of ASP2151 in Herpes Simplex PatientsCompletedNCT02209324Phase 3Results posted
- Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of AgeCompletedNCT02075515Phase 3Results posted
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal TransplantCompletedNCT02058589Phase 3Results posted
- Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and OlderCompletedNCT02052596Phase 3Results posted
- Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and OlderCompletedNCT02045836Phase 3Results posted
- Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold SoresCompletedNCT01985321Phase 2Results posted
- Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes LabialisCompletedNCT01971385Phase 1Results posted
- Phase III Study of ASP2151 in Herpes Zoster PatientsCompletedNCT01959841Phase 3Results posted
- Phase III Study of ASP2151 in Herpes Simplex PatientsCompletedNCT01959295Phase 3Results posted
- Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and OlderCompletedNCT01954251Phase 3Results posted
- Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold SoresCompletedNCT01902303Phase 2Results posted
- Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and CultureCompletedNCT01878383Results posted
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes ZosterCompletedNCT01827839Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving ChemotherapyCompletedNCT01798056Phase 3Results posted
- Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 YearsCompletedNCT01777321Phase 3Results posted
- Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in ItalyCompletedNCT01772160Results posted
- Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersCompletedNCT01767467Phase 3Results posted
- Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or OlderCompletedNCT01751165Phase 3Results posted
- Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital HerpesCompletedNCT01687595Phase 2Results posted
- Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173ACompletedNCT01610414Phase 3Results posted
- Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation PatientsCompletedNCT01602562Phase 3Results posted
- Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years OldCompletedNCT01574612Phase 3Results posted
- Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination RatesCompletedNCT01519570Not applicableResults posted
- Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue HospitalCompletedNCT01483378Not applicableResults posted
- Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) SheddingCompletedNCT01448616Phase 4Results posted
- Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus InfectionCompletedNCT01308424Phase 1/2Results posted
- Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy SubjectsCompletedNCT01295320Phase 2Results posted
- Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital HerpesCompletedNCT01281007Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)CompletedNCT01254630Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)CompletedNCT01229267Phase 3Results posted
- Botulinum Toxin A for Herpes LabialisTerminatedNCT01225341Not applicableResults posted
- Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and OlderCompletedNCT01165229Phase 3Results posted
- Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT01165203Phase 2Results posted
- Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and OlderCompletedNCT01165177Phase 3Results posted
- A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)CompletedNCT00942084Phase 1Results posted
- Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173ACompletedNCT00920218Phase 2Results posted
- A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes LabialisTerminatedNCT00913692Phase 2Results posted
- Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes LabialisCompletedNCT00878072Phase 2/3Results posted
- Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With NeutropeniaCompletedNCT00855309Phase 3Results posted
- Zinc for the Treatment of Herpes Simplex Labialis (HSL)CompletedNCT00809809Phase 3Results posted
- GUD Clinical and Virologic Response to Acyclovir in HIV Negative African WomenCompletedNCT00808405Not applicableResults posted
- Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 YearsCompletedNCT00802464Phase 2Results posted
- A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)CompletedNCT00535236Phase 1Results posted
- HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and BreastfeedingCompletedNCT00530777Phase 2Results posted
- Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVCompletedNCT00527618Phase 4Results posted
- Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black PatientsCompletedNCT00477334Phase 4Results posted
- Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding StudyCompletedNCT00464542Phase 4Results posted
- Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex InfectionCompletedNCT00448227Phase 2Results posted
- A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)CompletedNCT00322231Phase 3Results posted
- Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesCompletedNCT00306787Phase 3Results posted
- VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2CompletedNCT00306293Phase 4Results posted